source
- BD appoints Ferass Abuzaina as Worldwide President of SurgeryBecton, Dickinson and Company announced that Ferass Abuzaina will serve as the new Worldwide President of its Surgery business unit, effective immediately. He will oversee the global strategy, oper…
- Curium lists Bexlutry at $63,524 per infusion, roughly 5% cheaper than Novartis' LutatheraCurium announced the list price for its radioligand Bexlutry, a generic version of Novartis' Lutathera. The price is set at $63,524 per infusion, which represents about a five percent discount com…